Work Here?
About Medrio
Industries
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$32M
Headquarters
New York City, New York
Founded
2005
Overview
Medrio offers software solutions for clinical trials, focusing on a cloud-based platform that simplifies processes like protocol design and casebook submission. Its key feature, the Randomization and Trial Supply Management (RTSM) tool, helps clients manage trial supplies efficiently while minimizing risks. Medrio operates on a Software-as-a-Service (SaaS) model, charging subscription fees based on the features used, which provides a steady revenue stream. The company distinguishes itself with a user-friendly interface that allows researchers to focus on their work, aiming to enhance the efficiency of clinical trials.
Simplify's Take
What believers are saying
- Growing demand for decentralized trials boosts Medrio's eClinical solutions.
- No-code platforms align with Medrio's recent RTSM enhancements, enabling faster deployment.
- SOC 2 Type 2 certification strengthens Medrio's data security and client trust.
What critics are saying
- Emerging eClinical companies threaten Medrio's market share with innovative solutions.
- Rapid AI advancements may outpace Medrio's current capabilities, risking competitive edge.
- Decentralized trial demands could strain Medrio's resources if not scaled properly.
What makes Medrio unique
- Medrio offers a no-code RTSM solution, reducing setup time for clinical trials.
- The platform's user-friendly interface allows researchers to focus on science, not technology.
- Medrio's SaaS model provides a steady revenue stream through subscription fees.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$32M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Gym Membership
Flexible Work Hours
Unlimited Paid Time Off
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 2%Medrio, a global leader in clinical trial technology, announced enhancements to its randomization and trial supply management (RTSM) solution.
SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization and trial supply management (RTSM) solution. This latest release delivers faster implementation, greater flexibility, and enhanced self-service capabilities."Our customers need RTSM to be as agile as the trials they run," said Nicole Latimer, Chief Executive Officer at Medrio. "By expanding our configurability capabilities, we're allowing teams to build, test, and deploy Medrio RTSM in a fraction of the time of traditional systems without relying on extensive vendor support."The latest IRT Benchmarking & Market Dynamics (5th Ed.) report cites that 77% of clinical trials now require moderate to high-complexity RTSM builds. This finding highlights the need for flexible and configurable RTSM systems. Designed in collaboration with customers, Medrio RTSM eliminates the barriers and complexity of traditional vendor-dependent setups. With no-code configurability, sponsors and CROs can build and deploy in weeks, not months."The Medrio RTSM build team has been great to work with, showing knowledge, professionalism, flexibility, and the ability to meet study timelines," said Kenneth Homer, Director of Biostatistics and Programming at Homer Biometrics, LLC
London-based Phastar has previously partnered with Medrio, a decentralized clinical trial technology company, on a tool for data visualization.
CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce
AICPA SOC badge “Assuring the safety and security of our customers’ data, as they navigate FDA or EMA approval, is our highest priority, so we are thrilled when industry leading assessments - whether it be SOC 2, ISO 27001, or ISO 9001:2015 - attest to our daily practices and rigor.” said Fred Martin, COO. Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions
Medrio is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Medrio
Industries
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$32M
Headquarters
New York City, New York
Founded
2005
Medrio is Hiring for 1 Jobs on Simplify!
Find jobs on Simplify and start your career today